FierceBiotech:生物技术 //www.blue-donuts.com/ 一种从药用灌木中提取的新药如何阻断以前“不可用药”的乳腺癌靶点 //www.blue-donuts.com/beplay体育登录research/how-a-novel-drug-from-a-medicinal-shrub-blocks-a-previtory-undruggably-breast-cancer. How a novel drug from a medicinal shrub blocks a previously ‘undruggable’ breast cancer target arlene.weintraub Thu, 04/22/2021 - 12:02 星期四,4月22日2021年16:02:40 +0000 阿琳温特劳布 607176在//www.blue-donuts.com 一家初创公司旨在通过增强神经元的垃圾处理能力来治疗老年痴呆症 //www.blue-donuts.com/beplay体育登录research/treating-alzheimer-s-disease-by-invigoration-cell-s-specialized-gar-s-pecialized-gar-scleaning -system. 启动旨在通过调用神经元的垃圾处理能力 Aliu Thu,04/22/2021 - 06:29 2021年4月22日星期四10:29:44 +0000 安格斯刘 607116年//www.blue-donuts.com Anavo Therapeutics希望大型制药公司重新开始寻找磷酸酶药物 //www.blue-donuts.com/biotech/anavo-tharectics-wants-big-pharma-to-dust-off-their-shelves-search-phosphatase-drugs. <跨属性= "模式:“> Anavo疗法希望大型制药公司灰尘磷酸酶药物的货架上搜索< / span > < span rel = "模式:作者“> < span lang =“”=“//www.blue-donuts.com/user/52936”“=”模式:人”属性=”模式:名称“数据类型= " xml: lang = " " > aarmstrong < / span > < / span > <跨属性=”模式:dateCreated”内容= " 2021 - 04 - 21 t20:25:47 + 00:00”>结婚,04/21/2021 - 16:25 < / span > <跨类=“a2a_kit a2a_kit_size_32 addtoany_list”data-a2a-url = " //www.blue-donuts.com/biotech/anavo-therapeutics-wants-big-pharma-to-dust-off-their-shelves-search-phosphatase-drugs " data-a2a-title =“Anavo疗法希望大型制药公司灰尘磷酸酶药物的货架上搜索“> < class = " a2a_ddaddtoany_share " href = " https://www.addtoany.com/share url = https % % 2 f % 2 3 fwww.blue-donuts.com % 2 fbiotech % 2 fanavo-therapeutics-wants-big-pharma-to-dust-off-their-shelves-search-phosphatase-drugs&title = Anavo % 20疗法% 20希望% 20大% 20制药% 20 % 20灰尘% 20 % 20 % 20货架% 20在% 20搜索% 20 % 20磷酸酶% 20药”> < / > <类= " a2a_button_facebook " > < / > <类= " a2a_button_twitter " > < / > < class = " a2a_button_linkedin " > < / > < class = " a2a_button_email " > < / > < class = " a2a_button_print " > < / > < / span > 周三,4月21日2021年20:25:47 +0000 安娜-阿姆斯特朗 607071年//www.blue-donuts.com 将阿斯利康的“好”胆固醇促进剂与PCSK9抑制剂相结合,有望治疗心脏病 //www.blue-donuts.com/beplay体育登录research/combination-astrazeneca-s-booster-good-cholesterol-and-pcsk9-inhibition-shows-promise-for 将阿斯利康'good' cholesterol booster with PCSK9 inhibition联合起来,显示出了治疗心脏病的希望。< span rel="schema:author">aliu <类= " a2a_dd addtoany_share”href = " https://www.addtoany.com/share url = https % % 2 f % 2 3 fwww.fiercebibeplay体育登录otech.com % 2 fresearch % 2 fcombination-astrazeneca-s-booster-good-cholesterol-and-pcsk9-inhibition-shows-promise-for&title = % 20结合阿斯利康% 27 s % 27好% 20 27%胆固醇20% % 20助推器% 20 % 20 pcsk9 % 20抑制% 20显示% 20承诺% 20 % 20心中% 20疾病”> < / > <类= " a2a_button_facebook " > < / > <类= " a2a_button_twitter " > < / > < class = " a2a_button_linkedin " > < / > < class = " a2a_button_email " > < / > < class = " a2a_button_print " > < / > < / span > 2021年4月21日星期三10:45:58 +0000 安格斯刘 606971年//www.blue-donuts.com 阿斯利康(AstraZeneca)癌症研发主管Ferté退出 //www.blue-donuts.com/biotech/astrazeneca-cancer-r-d-exec-charles-ferte-hits-exit > <跨属性= "模式:名字阿斯利康癌症研发exec Ferte点击退出< / span > < span rel = "模式:作者“> < span lang =“”=“//www.blue-donuts.com/user/40596”“=”模式:人”属性=”模式:名称“数据类型= " xml: lang = " " > badams < / span > < / span > <跨属性=“模式:dateCreated”内容=“2021 - 04 - 21 - t07:46:27 + 00:00”>结婚,04/21/2021 - 03:46 < / > < class = " a2a_button_facebook " > < / > < class = " a2a_button_twitter " > < / > < class = " a2a_button_linkedin " > < / > <类= " a2a_button_email " > < / > <类= " a2a_button_print " > < / > < / span > 星期三,4月21日07:46:27 +0000 本亚当斯 606951年//www.blue-donuts.com 罗氏在第一季度清场中筛选了2种COVID-19药物候选药物 //www.blue-donuts.com/biotech/roche-culls-two-covid-drug-hopefuls-amid-q1-clear-out roche剔除2 covid-19药物希望Q1清除 badams WED,04 / SPAN> 2021年4月21日星期三07:27:02 +0000 本亚当斯 606941年//www.blue-donuts.com 卡尔维斯塔以一个临床持有的第二资产,随着财富的潮起潮落 //www.blue-donuts.com/biotech/kalvista-hit-a-clinical-hold-second-asset-as-fortunes-ebb-and-flow Kalvista以第二个资产的临床保留为FortUnes eBB和Flow badams Tue,04 / 20/2021 - 06:59 2021年4月20日星期二10:59:10 +0000 本亚当斯 606826在//www.blue-donuts.com 在礼来公司的帮助下,福布斯以3.6亿欧元完成了欧洲生命科学的最后一轮融资 //www.blue-donuts.com/biotech/forbion-closs-final-european-life-ciences-funding-round-at-eu360m-help-from-liilly. <跨属性= "模式:“> Forbion关闭欧洲生命科学资助的最后一轮在€360在礼来公司的帮助下< / span > < span rel = "模式:作者“> < span lang =“”=“//www.blue-donuts.com/user/40596”“=”模式:人”属性=“模式:名称”数据类型= " xml: lang = " " > badams < / span > < / span > <跨属性=”模式:dateCreated”内容= " 2021 - 04 - 20 - t08:17:12 + 00:00”>,星期二04/20/2021——04:17 < / span > <跨类=“a2a_kit a2a_kit_size_32 addtoany_list”data-a2a-url = " //www.blue-donuts.com/biotech/forbion-closes-final-european-life-sciences-funding-round-at-eu360m-help-from-eli-lilly " data-a2a-title =“欧洲生命科学Forbion关闭最后一轮融资€360在礼来公司的帮助下“> < class = " a2a_ddaddtoany_share " href = " https://www.addtoany.com/share url = https % % 2 f % 2 3 fwww.blue-donuts.com % 2 fbiotech % 2 fforbion-closes-final-european-life-sciences-funding-round-at-eu360m-help-from-eli-lilly&title = Forbion % 20关闭% 20最后% 20欧洲% 20生命% 20科学% 20资金% 20轮以20% % % 20 e2 % 82% ac360m % 20 % 20帮助% 20 % 20 eli % 20莉莉“> < / > <类= " a2a_button_facebook " > < / > <类= " a2a_button_twitter " > < / > < class = " a2a_button_linkedin " > < / > < class = " a2a_button_email " > < / > < class = " a2a_button_print " > < / > < / span > 星期二,20日4月20日08:17:12 +0000 本亚当斯 606816年//www.blue-donuts.com Epizyme的EzH2阻滞剂在前列腺癌模型中提高免疫肿瘤响应 //www.blue-donuts.com/beplay体育登录research/epizyme-s-ezh2-blocker-boosts-immuno-oncology-response-prostate-cancer-models arlene。weintraub 周一,04/19/2021——09:02 < / span > <跨类=“a2a_kit a2a_kit_size_32 addtoany_list”data-a2a-url = " //www.blue-donuts.com/resbeplay体育登录earch/epizyme-s-ezh2-blocker-boosts-immuno-oncology-response-prostate-cancer-models " data-a2a-title =“Epizyme EZH2拦截器提高immuno-oncology反应在前列腺癌模型”> < class = " a2a_dd addtoany_share”href = " https://www.addtoany.com/share url = https % % 2 f % 2 3 fwww.fiercebibeplay体育登录otech.com % 2 fresearch % 2 fepizyme-s-ezh2-blocker-boosts-immuno-oncology-response-prostate-cancer-models&title = Epizyme % 27 s % 20 ezh2 % 20阻滞剂% 20增加% 20 immuno-oncology % 20响应% 20 % 20前列腺癌症% 20 % 20模型”> < / > < class = " a2a_button_facebook " > < / > <类= " a2a_button_twitter " > < / > <类= " a2a_button_linkedin " > < / > < class = " a2a_button_email " > < / > < class = " a2a_button_print " > < / > < / span > 2021年4月19日星期一13:02:06 +0000 阿琳温特劳布 606701年//www.blue-donuts.com Adagio为定制Covid-19毒品战斗提升了一个怪物336米 //www.blue-donuts.com/biotech/adagio-raises-a-monster-336m-round-for-bespoke-covid-drug-battle Adagio raises a monster $ 3.36 m round for bespoke COVID-19 drug battle badams < / > < class = " a2a_button_twitter " > < / > <类= " a2a_button_linkedin " > < / > <类= " a2a_button_email " > < / > < class = " a2a_button_print " > < / > < / span > 星期一,4月19日10:59:09 +0000 本亚当斯 606681年//www.blue-donuts.com 3家截然不同的生物科技公司都为同一个IPO目标提交了申请:在纳斯达克(Nasdaq)大幅筹资 https://www.fificebiotech.com/biotech/three-very-different-biotechs-all-file-for-same-ipo-goal-a-big-raise-nasdaq. 3个非常不同的生物技术都为相同的IPO目标文件:< span rel="schema:author">badams Mon,04/19/2021 - 04:05 < class = " a2a_dd addtoany_share“href = " https://www.addtoany.com/share url = https % 3 A % 2 f % 2 fwww.blue-donuts.com % 2 fbiotech % 2 fthree-very-different-biotechs-all-file-for-same-ipo-goal-a-big-raise-nasdaq&title = 3% 20非常% 20个不同% 20生物技术% 20所有% 20文件% 20 % 20 % 20相同的% 20 ipo % 20目标% 3 % 20 % 20大% 20提高% 20 % 20纳斯达克”> < / > <类= " a2a_button_facebook " > < / > <类= " a2a_button_twitter " > < / > < class = " a2a_button_linkedin " > < / > < class = " a2a_button_email " > < / > < class = " a2a_button_print " > < / > < / span > 2021年4月19日星期一08:05:32 +0000 本亚当斯 606671年//www.blue-donuts.com Tonix希望与oagen签订抗病毒协议,为COVID-19药物提供补品 //www.blue-donuts.com/biotech/tonix-hopes-for-covid-drug-tonic-as-it-pens-oyagen-antiviral-pact <跨属性= "模式:“> Tonix希望COVID-19药物滋补,笔OyaGen抗病毒协定< / span > < span rel = "模式:作者“> < span lang =“”=“//www.blue-donuts.com/user/40596”“=”模式:人”属性=”模式:名称“数据类型= " xml: lang = " " > badams < / span > < / span > <跨属性=”模式:dateCreated”内容= " 2021 - 04 - 17 t12:46:48 + 00:00”>坐,04/17/2021——08:46 < / span > <跨类=“a2a_kit a2a_kit_size_32 addtoany_list”data-a2a-url = " //www.blue-donuts.com/biotech/tonix-hopes-for-covid-drug-tonic-as-it-pens-oyagen-antiviral-pact " data-a2a-title =“Tonix希望COVID-19药物滋补笔OyaGen抗病毒协定”> < class = " a2a_dd addtoany_share”href = " https://www.addtoany.com/share url = https % % 2 f % 2 3 fwww.blue-donuts.com % 2 fbiotech % 2 ftonix-hopes-for-covid-drug-tonic-as-it-pens-oyagen-antiviral-pact&title = Tonix % 20希望% 20 % 20 covid-19 % 20药物% 20主音% 20 % 20,% 20笔% 20 oyagen % 20抗病毒% 20协议% 20 " > < / > < class = " a2a_button_facebook " > < / > < class = " a2a_button_twitter " > < / > <类= " a2a_button_linkedin " > < / > <类= " a2a_button_email " > < / > < class = " a2a_button_print " > < / > < / span > 2021年4月17日星期六12:46:48 +0000 本亚当斯 606661在//www.blue-donuts.com 人工智能药物勘探公司递归(Recursion)将IPO(再次)提升至3.74亿美元 //www.blue-donuts.com/biotech/ai-drug-prospector-recursion-bumps-ipo-up-again-to-374m. aalidrus < / > < class = " a2a_button_twitter " > < / > < class = " a2a_button_linkedin " > < / > <类= " a2a_button_email " > < / > <类= " a2a_button_print " > < / > < / span > 星期五,2021年4月16日14:42:01 +0000 Amirah Al Idrus 606616年//www.blue-donuts.com 这种普通的心脏病药物能通过预防炎症来治疗肥胖吗? //www.blue-donuts.com/beplay体育登录research/could-common-heart-drug-defeat-obesity-by-preventing-inflamation. 可以通过防止炎症击败肥胖肥胖? arlene.weintraub FRI,04/16/2021 - 08:18 < / > <类= " a2a_button_linkedin " > < / > < class = " a2a_button_email " > < / > < class = " a2a_button_print " > < / > < / span > 2021年4月16日星期五12:18:56 +0000 阿琳温特劳布 606576年//www.blue-donuts.com Precision从Servier那里重新获得了异基因car - t的权利 //www.blue-donuts.com/biotech/precision-reacquires-rights-to-allogeneic-car-ts-from-servier Precision从Servier重新获得异基因car - t的权利< span rel="schema:author">ntaylor < / > < class = " a2a_button_twitter " > < / > < class = " a2a_button_linkedin " > < / > <类= " a2a_button_email " > < / > <类= " a2a_button_print " > < / > < / span > 2021年4月16日星期五11:47:17 +0000 尼克保罗 606536在//www.blue-donuts.com EMA开始审查GSK和Vir的COVID-19抗体治疗 //www.blue-donuts.com/biotech/ema-starts-review-gsk-and-vir-s-covid-19-antibody-therapy. EMA开始回顾GSK和Vir的COVID-19抗体疗法< span rel="schema:author">ntaylor < / > < class = " a2a_button_twitter " > < / > < class = " a2a_button_linkedin " > < / > <类= " a2a_button_email " > < / > <类= " a2a_button_print " > < / > < / span > 星期五,2011年4月16日10:39:49 +0000 尼克保罗 606526年//www.blue-donuts.com Rapha Capital Management通过早期科学推出100亿美元的生命科学VC基金 //www.blue-donuts.com/biotech/rapha-capital-management-launches-100m-life-science-vc-fund-eye-early-science Rapha资本管理在早期科学中推出100米生命的生命科学VC基金 badams FRI,04/16/2021 - 03:25 <一个类=“a2a_button_email”> 周五,4月16日07:25:08 +0000 本亚当斯 606516年//www.blue-donuts.com 滑道和梯子 - Lilly,竞标Adieu到Shah,将Apple Exec排队为CDO //www.blue-donuts.com/biotech/chutes-ladders-lilly-bidding-adieu-to-shah-lines-up-apple-exec-as-cdo. fkansteiner Thu,04/15/2021 - 23:52 < / > <类= " a2a_button_twitter " > < / > < class = " a2a_button_linkedin " > < / > < class = " a2a_button_email " > < / > < class = " a2a_button_print " > < / > < / span > 星期五,2021年4月16日03:52:44 +0000 干酪坎斯坦纳 606506年//www.blue-donuts.com 默克公司将一种新型冠状病毒药物装进罐中,放弃另一种药物的临床试验 https://www.fificebiotech.com/biotech/monck-cansoone-covid-19-drug-scraps-a-clinical-trial-another. 默克公司可以装一种COVID-19药物, >ntaylor Thu,04/15/2021 - 08:06 < / > <类= " a2a_button_twitter " > < / > < class = " a2a_button_linkedin " > < / > < class = " a2a_button_email " > < / > < class = " a2a_button_print " > < / > < / span > 2021年4月15日星期四12:06:37 +0000 尼克保罗 606401年//www.blue-donuts.com 科学家们为医学研究做出了长期但有争议的人类猴胚胎beplay体育登录 //www.blue-donuts.com/beplay体育登录research/a-controversial-breakthrough-scientists-generate-long-lasting-human-monkey-chimeric 科学家们对医学研究的持久但有争议的人猴胚胎 Aliu Thu,04/15/2021 - 08:06 2021年4月15日星期四12:06:11 +0000 安格斯刘 606406年//www.blue-donuts.com 在ICOS药物跌倒后,GSK停止Keytruda Combo试验 //www.blue-donuts.com/biotech/gsk-stops-keytruda-combo-trials-after-icos-drug-falls-short GSK在ICOS药物失败后停止Keytruda combo试验< span rel="schema:author">ntaylor < / > < class = " a2a_button_twitter " > < / > < class = " a2a_button_linkedin " > < / > <类= " a2a_button_email " > < / > <类= " a2a_button_print " > < / > < / span > 2021年4月15日星期四11:07:33 +0000 尼克保罗 606386在//www.blue-donuts.com 新名称、新板、新焦点:利他生物以6300万美元的A轮融资重新启动 //www.blue-donuts.com/biotech/altrubio-relaunches-new-board-ceo 新名称,新董事会,新焦点:altrubio重新启动以$ 63m系列a aarmstrong WED,04/14/2021 - 15:56 2021年4月14日星期三19:56:58 +0000 安娜-阿姆斯特朗 606336年//www.blue-donuts.com 蓝鸟,PsiOxus显示溶瘤病毒在实体肿瘤中增加CAR-T //www.blue-donuts.com/biotech/bluebird-psioxus-show-oncolytic-virus-boosts-car-t-solid-tumors <跨属性= "模式:“>蓝知更鸟,PsiOxus显示溶瘤细胞的病毒在实体肿瘤促进CAR-T < / span > < span rel = "模式:作者“> < span lang =“”=“//www.blue-donuts.com/user/39341”“=”模式:人”属性=”模式:名称“数据类型= " xml: lang = " " > ntaylor跨度< / > < / span > <跨属性=“模式:dateCreated”内容=“2021 - 04 - 14 - t12:44:03 + 00:00”>结婚,04/14/2021 - 08:44 < / > <类= " a2a_button_twitter " > < / > < class = " a2a_button_linkedin " > < / > < class = " a2a_button_email " > < / > < class = " a2a_button_print " > < / > < / span > 星期三,4月14日2021年12:44:03 +0000 尼克保罗 606231年//www.blue-donuts.com 巴尔加瓦离开吉利德,担任生物科技投资者MPM的职位 //www.blue-donuts.com/biotech/bhargava-leaves-gilead-to-take-up-post-at-biotech-investor-mpm Bhargava叶gilead在生物技术投资者MPM ntaylor WED,04/14/2021 - 07:59 2021年4月14日星期三11:59:24 +0000 尼克保罗 606221年//www.blue-donuts.com 森提生物科学公司斥资6.45亿美元与Spark公司签署协议,将把基因电路推向快车道 //www.blue-donuts.com/biotech/senti-biosciences-645m-spark-pact-to-drive-gene-circuits-into-fast-lane Senti Biosciences以645米的火花协议将基因电路驱动到快速车道 badams 周三,04/14/2021 - 07:49 2021年4月14日星期三11:49:41 +0000 本亚当斯 606211年//www.blue-donuts.com